Back
Atara Biotherapeutics Stock Price Chart
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free
Buy
58
ATRA
Atara Biotherapeutics
Last Price:
$15.63
Seasonality Move:
5.9%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free-
The current trend is moderately bullish and ATRA is experiencing slight selling pressure.
Atara Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.5 | Buy |
| 20-day SMA: | 12.99 | Buy |
| 50-day SMA: | 12.11 | Buy |
| 200-day SMA: | 11.59 | Buy |
| 8-day EMA: | 15.45 | Buy |
| 20-day EMA: | 13.92 | Buy |
| 50-day EMA: | 12.3 | Buy |
| 200-day EMA: | 14.24 | Buy |
Atara Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.34 | Buy |
| Relative Strength Index (14 RSI): | 60.5 | Buy |
| Chaikin Money Flow: | -9811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.7 - 15.12) | Buy |
| Bollinger Bands (100): | (7.57 - 12.61) | Buy |
Atara Biotherapeutics Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 15.55 while ATRA 8-day simple moving average is 15.50, which is a Buy signal.
-
The stock price of ATRA is 15.55 while Atara Biotherapeutics 20-day SMA is 12.99, which makes it a Buy.
-
Atara Biotherapeutics 50-day simple moving average is 12.11 while ATRA share price is 15.55, making it a Buy technically.
-
ATRA stock price is 15.55 and Atara Biotherapeutics 200-day simple moving average is 11.59, creating a Buy signal.
ATRA Technical Analysis vs Fundamental Analysis
Buy
58
Atara Biotherapeutics (ATRA)
is a Buy
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a BuyThe current Atara Biotherapeutics [ATRA] share price is $15.55. The Score for ATRA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
89.6M
Price in USD:
15.55
Share Volume:
80.2K
Atara Biotherapeutics 52-Week Range
52-Week High:
39.50
52-Week Low:
6.50
Buy
58
Atara Biotherapeutics (ATRA)
is a Buy
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?The Atara Biotherapeutics stock price is 15.55 USD today.
-
Will ATRA stock go up or go down?Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Atara Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is not overvalued.
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 15.55 while ATRA 8-day exponential moving average is 15.45, which is a Buy signal.
-
The stock price of ATRA is 15.55 while Atara Biotherapeutics 20-day EMA is 13.92, which makes it a Buy.
-
Atara Biotherapeutics 50-day exponential moving average is 12.30 while ATRA share price is 15.55, making it a Buy technically.
-
ATRA stock price is 15.55 and Atara Biotherapeutics 200-day simple moving average is 14.24, creating a Buy signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $11.80 per share, a decrease next quarter of $0.00 per share, a decrease this year of $10.45 per share, and an increase next year of $5.50 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
-
ATRA Moving Average Covergence Divergence (MACD) indicator is 1.34, suggesting Atara Biotherapeutics is a Buy
-
Atara Biotherapeutics Relative Strength Index (RSI) is 60.5, which suggest Atara Biotherapeutics is overbought
-
The Bollinger Bands (25) for Atara Biotherapeutics is (10.7 - 15.12), which suggest Atara Biotherapeutics is a Buy
-
The Bollinger Bands (100) for Atara Biotherapeutics is (7.57 - 12.61), which suggest Atara Biotherapeutics is a Buy
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.